SANA Q2 2024 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$900M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$49M

Net Income

-$50M

EPS (Diluted)

$-0.21

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$59M

Free Cash Flow

-$72M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$619M

Total Liabilities

$279M

Stockholders' Equity

$340M

Cash & Equivalents

$135M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$49M	-$116M	+57.5%
Net Income	-$50M	-$114M	+55.9%